Chevy Chase Trust Holdings LLC Has $79.79 Million Holdings in Danaher Corporation (NYSE:DHR)

Chevy Chase Trust Holdings LLC decreased its holdings in Danaher Corporation (NYSE:DHRFree Report) by 1.4% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 389,198 shares of the conglomerate’s stock after selling 5,340 shares during the quarter. Chevy Chase Trust Holdings LLC owned 0.05% of Danaher worth $79,786,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Vanguard Group Inc. lifted its position in Danaher by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 59,750,122 shares of the conglomerate’s stock valued at $13,715,641,000 after acquiring an additional 315,912 shares in the last quarter. Geode Capital Management LLC lifted its position in Danaher by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 13,358,206 shares of the conglomerate’s stock valued at $3,056,996,000 after acquiring an additional 315,446 shares in the last quarter. Norges Bank bought a new position in Danaher in the 4th quarter valued at about $2,130,740,000. Bank of New York Mellon Corp lifted its position in Danaher by 5.4% in the 4th quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate’s stock valued at $1,971,609,000 after acquiring an additional 441,012 shares in the last quarter. Finally, Northern Trust Corp lifted its position in Danaher by 14.3% in the 4th quarter. Northern Trust Corp now owns 7,934,991 shares of the conglomerate’s stock valued at $1,821,477,000 after acquiring an additional 992,594 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Activity at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the business’s stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the sale, the chairman now directly owns 3,105,808 shares of the company’s stock, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president now directly owns 15,179 shares of the company’s stock, valued at $3,005,442. This represents a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.20% of the stock is owned by company insiders.

Analyst Ratings Changes

DHR has been the topic of several recent analyst reports. Evercore ISI dropped their target price on shares of Danaher from $240.00 to $230.00 and set an “outperform” rating on the stock in a research report on Tuesday, April 22nd. Royal Bank Of Canada reissued an “outperform” rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Wolfe Research dropped their target price on shares of Danaher from $275.00 to $220.00 and set an “outperform” rating on the stock in a research report on Monday, April 7th. JPMorgan Chase & Co. dropped their target price on shares of Danaher from $280.00 to $260.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 22nd. Finally, Leerink Partners lifted their target price on shares of Danaher from $225.00 to $230.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and an average target price of $248.17.

Get Our Latest Stock Analysis on Danaher

Danaher Stock Up 0.0%

Danaher stock opened at $196.49 on Tuesday. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $281.70. The firm has a market capitalization of $140.62 billion, a price-to-earnings ratio of 38.15, a P/E/G ratio of 2.76 and a beta of 0.77. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a 50 day simple moving average of $193.96 and a 200 day simple moving average of $209.14.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Danaher had a net margin of 15.81% and a return on equity of 10.80%. The business had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. On average, analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.65%. Danaher’s dividend payout ratio is 24.85%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.